Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.32B |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$975M |
| 3 |
AABA
Altaba Inc
AABA
|
+$871M |
| 4 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$372M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$338M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.62B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$1.02B |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$860M |
| 4 |
Microsoft
MSFT
|
+$594M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$517M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.12% |
| 2 | Healthcare | 4.92% |
| 3 | Financials | 4.07% |
| 4 | Consumer Discretionary | 3.64% |
| 5 | Communication Services | 3.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YELL
3951
PUT
DELISTED
Yellow Corporation Common Stock
YELL
| $300K | ﹤0.01% |
27,000
+22,900
| +559% | +$228K |
|
|
GCI
3952
DELISTED
Gannett Co., Inc
GCI
| $300K | ﹤0.01% |
34,345
-8,380
| -20% | -$69.2K |
|
3953
Cogent Communications
CCOI
$505M
| $299K | ﹤0.01% |
7,458
+6,623
| +793% | +$274K |
|
3954
iShares Russell 2000 Growth ETF
IWO
$14.9B
| $299K | ﹤0.01% |
1,770
-1,531
| -46% | -$252K |
|
|
SGMO
3955
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $299K | ﹤0.01% |
34,008
-9,275
| -21% | -$59.5K |
|
3956
PUT
Vanguard Morningstar Total Stock Market ETF
VTI
$692B
| $299K | ﹤0.01% |
2,400
-2,700
| -53% | -$333K |
|
|
BIG
3957
PUT
DELISTED
Big Lots, Inc.
BIG
| $299K | ﹤0.01% |
6,200
+1,600
| +35% | +$77.9K |
|
|
ITG
3958
DELISTED
Investment Technology Group Inc
ITG
| $299K | ﹤0.01% |
14,073
-1,912
| -12% | -$39K |
|
3959
Gogo Inc
GOGO
$468M
| $298K | ﹤0.01% |
25,890
-170,664
| -87% | -$2.08M |
|
3960
PUT
iShares Russell 2000 Value ETF
IWN
$14.5B
| $297K | ﹤0.01% |
2,500
-2,600
| -51% | -$306K |
|
3961
Manitowoc
MTW
$680M
| $297K | ﹤0.01% |
12,342
-25,727
| -68% | -$602K |
|
|
SA
3962
CALL
Seabridge Gold
SA
$3.38B
| $297K | ﹤0.01% |
27,500
-14,600
| -35% | -$155K |
|
3963
Snap
SNAP
$9.06B
| $297K | ﹤0.01% |
16,669
-49,355
| -75% | -$995K |
|
|
HNP
3964
CALL
DELISTED
Huaneng Power Intl, Inc.
HNP
| $297K | ﹤0.01% |
10,700
+10,600
| +10,600% | +$304K |
|
|
ACHN
3965
DELISTED
Achillion Pharmaceuticals
ACHN
| $297K | ﹤0.01% |
64,915
-18,363
| -22% | -$73.8K |
|
3966
Cytokinetics
CYTK
$10.4B
| $296K | ﹤0.01% |
24,466
+17,064
| +231% | +$237K |
|
3967
Frontline
FRO
$8.62B
| $296K | ﹤0.01% |
51,786
-88,533
| -63% | -$544K |
|
3968
PUT
Jazz Pharmaceuticals
JAZZ
$16.7B
| $296K | ﹤0.01% |
1,900
-16,100
| -89% | -$2.46M |
|
3969
Supernus Pharmaceuticals
SUPN
$2.74B
| $296K | ﹤0.01% |
6,855
-1,054
| -13% | -$37.5K |
|
3970
Portland General Electric
POR
$5.65B
| $295K | ﹤0.01% |
6,466
-10,669
| -62% | -$492K |
|
3971
CALL
UBS Group
UBS
$177B
| $295K | ﹤0.01% |
17,400
+14,300
| +461% | +$232K |
|
|
NAGE
3972
Niagen Bioscience
NAGE
$241M
| $295K | ﹤0.01% |
77,288
+65,471
| +554% | +$207K |
|
|
TUP
3973
CALL
DELISTED
Tupperware Brands Corporation
TUP
| $295K | ﹤0.01% |
4,200
-28,300
| -87% | -$1.97M |
|
|
RVNC
3974
DELISTED
Revance Therapeutics, Inc.
RVNC
| $294K | ﹤0.01% |
11,172
-8,840
| -44% | -$197K |
|
3975
Columbus McKinnon
CMCO
$567M
| $293K | ﹤0.01% |
11,566
+11,120
| +2,493% | +$288K |
|
Similar funds
Barclays's Q2 2017 Portfolio in Review
As of Q2 2017, Barclays held 7,324 positions worth $93.4B, up 1.6% from $91.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays's Q2 2017 filing shows 436 new, 3,303 increased, 2,734 reduced and 395 closed positions. Its largest new stake was Altaba Inc: 16,007,195 shares worth $872M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, up from 5.7% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q2 2017 buy was Altaba Inc: 16,007,195 shares worth $872M.
- Barclays added most to Invesco QQQ Trust in Q2 2017, an estimated $3.32B increase.
- Barclays's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
- Barclays fully exited Yahoo Inc in Q2 2017, selling an estimated $174M.
- Barclays's ten largest holdings make up 32% of its $93.4B portfolio in Q2 2017.
- Barclays opened 436 new positions and closed 395 in Q2 2017.
- Barclays's portfolio value rose 1.6% quarter-over-quarter to $93.4B.
Based on Barclays's 13F filing for Q2 2017, filed 14 Aug 2017.